The Situation Arcus Biosciences Inc (NYSE: RCUS) shares – a clinical-stage biopharmaceutical company developing and commercializing cancer therapies – plunged on Tuesday after data it shared data relevant to its lung cancer drug. As of 12:00 PM ET, Arcus shares are down by 31.76%. The Explanation Arcus Inc officially went